41 results
S-1
EX-10.13
GLYC
GlycoMimetics Inc
4 Oct 13
IPO registration
12:00am
to continue in the employ of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company … to enter into a “same day sale” commitment, if applicable, with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA
8-K
EX-99.2
GLYC
GlycoMimetics Inc
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am
Board, I offer sincere thanks to Rachel for her leadership of GlycoMimetics and for her commitment to the company’s employees and to patients who
8-K
EX-99.1
GLYC
GlycoMimetics Inc
7 Nov 19
Glycomimetics Reports Third Quarter 2019 Financial
8:35am
to meet the primary endpoint and key secondary endpoints.
As part of a commitment to eliminate certain non-core research and development spending
8-K
EX-99.1
GLYC
GlycoMimetics Inc
1 May 20
Glycomimetics Reports Operational Highlights and Financial Results for
9:00am
Institute
Reiterated a commitment to determine what, if any, next steps to take with respect to the rivipansel program following transfer from Pfizer
S-1
EX-10.11
vcv ahpa334h
4 Oct 13
IPO registration
12:00am
S-1
EX-10.10
waa6v593qqe5u
4 Oct 13
IPO registration
12:00am
8-K
EX-10.1
dlmvtxmu bh
20 May 22
Departure of Directors or Certain Officers
1:09pm
S-1
EX-10.9
7dvoa dcjhiikrc
4 Oct 13
IPO registration
12:00am
S-1
EX-10.2
v1ta85 7g8
4 Oct 13
IPO registration
12:00am
S-1
EX-3.1
0t9i ne9rue1np1o
4 Oct 13
IPO registration
12:00am